Evidence map›Paper›PMID 34885050›Full record

ArticleCancers2021

Bridging the Species Gap: Morphological and Molecular Comparison of Feline and Human Intestinal Carcinomas.

Tanja Groll, Franziska Schopf, Daniela Denk, Carolin Mogler, Ulrike Schwittlick, Heike Aupperle-Lellbach, Sabrina Rim Jahan Sarker, Nicole Pfarr, Wilko Weichert, Kaspar Matiasek and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. The oncogenome of the domestic cat.Science (New York, N.Y.) · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Tanja GrollInstitute of Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.ORCID 0000-0002-9049-9145
Franziska SchopfInstitute of Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
Daniela DenkInstitute of Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
Carolin MoglerInstitute of Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.ORCID 0000-0003-3400-7254
Ulrike SchwittlickLABOKLIN GmbH & Co. KG, 97688 Bad Kissingen, Germany.
Heike Aupperle-LellbachLABOKLIN GmbH & Co. KG, 97688 Bad Kissingen, Germany.
Sabrina Rim Jahan SarkerInstitute of Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
Nicole PfarrInstitute of Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.ORCID 0000-0002-5977-5375
Wilko WeichertInstitute of Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
Kaspar MatiasekInstitute of Veterinary Pathology, Center for Clinical Veterinary Medicine, Ludwig-Maximilians-Universitaet (LMU), 80539 Munich, Germany.
Moritz JesinghausInstitute of Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
Katja SteigerInstitute of Pathology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.ORCID 0000-0002-7269-5433
Technical University of Munich · DELaboklin (Germany) · DELudwig-Maximilians-Universität München · DEPhilipps University of Marburg · DE

Funding

Cusanuswerk, Bischöfliche Studienförderung, Bonn, Germany ScholarshipDeutsche Forschungsgemeinschaft 36037240Deutsche Forschungsgemeinschaft 395357507
6 · The paper itself

Abstract

Limited availability of in vivo experimental models for invasive colorectal cancer (CRC) including metastasis and high tumor budding activity is a major problem in colorectal cancer research. In order to compare feline and human intestinal carcinomas, tumors of 49 cats were histologically subtyped, graded and further characterized according to the human WHO classification. Subsequently, feline tumors were compared to a cohort of 1004 human CRC cases. Feline intestinal tumors closely resembled the human phenotype on a histomorphological level. In both species, adenocarcinoma not otherwise specified (ANOS) was the most common WHO subtype. In cats, the second most common subtype of the colon (36.4%), serrated adenocarcinoma (SAC), was overrepresented compared to human CRC (8.7%). Mucinous adenocarcinoma (MAC) was the second most common subtype of the small intestine (12.5%). Intriguingly, feline carcinomas, particularly small intestinal, were generally of high tumor budding (Bd) status (Bd3), which is designated an independent prognostic key factor in human CRC. We also investigated the relevance of feline

Indexed as

colorectal cancercomparative oncologyCTNNB1spontaneous feline intestinal tumorstumor budding

Identifiers

PMID34885050
PMCPMC8656578
OpenAlexW3215062009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.